These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 15043139
21. Anti-HIV-Active Nucleoside Triphosphate Prodrugs. Jia X, Schols D, Meier C. J Med Chem; 2020 Jun 11; 63(11):6003-6027. PubMed ID: 32421343 [Abstract] [Full Text] [Related]
22. Synthesis, hydrolysis and anti-EBV activity of a series of 3'-modified cycloSal-BVDUMP pronucleotides. Meier C, Lomp A, Meerbach A, Wutzler P. Nucleosides Nucleotides Nucleic Acids; 2001 Jun 11; 20(4-7):307-14. PubMed ID: 11563042 [Abstract] [Full Text] [Related]
23. Bis-cycloSal-d4T-monophosphates: drugs that deliver two molecules of bioactive nucleotides. Ducho C, Görbig U, Jessel S, Gisch N, Balzarini J, Meier C. J Med Chem; 2007 Mar 22; 50(6):1335-46. PubMed ID: 17328534 [Abstract] [Full Text] [Related]
24. Nucleoside Diphosphate Prodrugs: Nonsymmetric DiPPro-Nucleotides. Weinschenk L, Schols D, Balzarini J, Meier C. J Med Chem; 2015 Aug 13; 58(15):6114-30. PubMed ID: 26125628 [Abstract] [Full Text] [Related]
25. CycloSal-BVDUMP pronucleotides: how to convert an antiviral-inactive nucleoside analogue into a bioactive compound against EBV. Meier C, Lomp A, Meerbach A, Wutzler P. J Med Chem; 2002 Nov 07; 45(23):5157-72. PubMed ID: 12408726 [Abstract] [Full Text] [Related]
26. The DiPPro approach: synthesis, hydrolysis, and antiviral activity of lipophilic d4T diphosphate prodrugs. Schulz T, Balzarini J, Meier C. ChemMedChem; 2014 Apr 07; 9(4):762-75. PubMed ID: 24616176 [Abstract] [Full Text] [Related]
27. Cyclosaligenyl-2',3'-didehydro-2',3'-dideoxythymidine monophosphate: efficient intracellular delivery of d4TMP. Balzarini J, Aquaro S, Knispel T, Rampazzo C, Bianchi V, Perno CF, De Clercq E, Meier C. Mol Pharmacol; 2000 Nov 07; 58(5):928-35. PubMed ID: 11040039 [Abstract] [Full Text] [Related]
28. cycloSal-PMEA and cycloAmb-PMEA: potentially new phosphonate prodrugs based on the cycloSal-pronucleotide approach. Meier C, Görbig U, Müller C, Balzarini J. J Med Chem; 2005 Dec 15; 48(25):8079-86. PubMed ID: 16335932 [Abstract] [Full Text] [Related]
29. Doubly loaded cycloSaligenyl-pronucleotides - 5,5'-Bis-(cycloSaligenyl-2',3'-dideoxy-2',3'-didehydrothymidine monophosphates). Gisch N, Balzarini J, Meier C. J Med Chem; 2009 Jun 11; 52(11):3464-73. PubMed ID: 19438207 [Abstract] [Full Text] [Related]
30. SATE pronucleotide approaches: an overview. Peyrottes S, Egron D, Lefebvre I, Gosselin G, Imbach JL, Périgaud C. Mini Rev Med Chem; 2004 May 11; 4(4):395-408. PubMed ID: 15134542 [Abstract] [Full Text] [Related]
31. Pronucleotides of 2',3'-Dideoxy-2',3'-Didehydrothymidine as Potent Anti-HIV Compounds. Jia X, Schols D, Meier C. J Med Chem; 2023 Sep 14; 66(17):12163-12184. PubMed ID: 37647547 [Abstract] [Full Text] [Related]
32. Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudine. Saboulard D, Naesens L, Cahard D, Salgado A, Pathirana R, Velazquez S, McGuigan C, De Clercq E, Balzarini J. Mol Pharmacol; 1999 Oct 14; 56(4):693-704. PubMed ID: 10496951 [Abstract] [Full Text] [Related]